FDA Appoints Bret Koplow as Acting Director of CTP

May.21

According to the U.S. Food and Drug Administration’s website, Bret Koplow has been appointed acting director of the Center for Tobacco Products (CTP). Koplow has been with the FDA since 2011, holding several key roles, most recently serving as senior advisor to the FDA Commissioner.

On May 20, according to the official website of the Center for Tobacco Products (CTP) of the US Food and Drug Administration (FDA), Dr. Bret Koplow has been appointed as the Acting Director of the Center for Tobacco Products.

美国FDA任命Bret Koplow为烟草制品中心代理主任 — Leadership information on the CTP official website｜Image source: CTP

Resume information indicates that Dr. Brett Koplow was appointed as Acting Director of the Center for Tobacco Products (CTP) at the Food and Drug Administration in May 2025. In this role, Dr. Coplow is responsible for ensuring that the CTP achieves its public health goals and puts into practice the center's vision and mission in implementing the Family Smoking Prevention and Tobacco Control Act.

According to Bloomberg, FDA Commissioner Marty Makary stated in an internal email that senior FDA official Bret Koplow will temporarily assume the position.

According to Koplow' s LinkedIn page, he has been working at the FDA since 2011. Within the agency, he has held various positions, most recently serving as a senior advisor to the FDA Commissioner.

In April, the United States Department of Health and Human Services (HHS), under the leadership of Robert Kennedy Jr., carried out a large-scale layoff, resulting in the dismissal of Brian King, who was the Director of the Center for Tobacco Products (CTP) at the time. In May, The Campaign for Tobacco-Free Kids announced on its official website that Brian King had been appointed as the Executive Vice President for the U.S. program, tasked with leading the organization's efforts at the federal, state, and local levels.

References:

[1] 领英网信息

[2] FDA CTP信息

[3] FDA Names Acting Leaders for Inspections, Tobacco Regulation

Also Read:

[1] Former Head of FDA’s Tobacco Center, Brian King, Joins the Campaign for Tobacco-Free Kids

[2] High-Level Changes and Layoffs at FDA Spark Controversy

[3] FDA CTP Director Brian King: New Guidelines on Fines to be Released This Summer

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Moroccan Government Rejects Opposition Proposal to Increase Excise Tax on E-Cigarettes

Moroccan government has firmly rejected proposals from opposition parties to increase the internal consumption tax (TIC) on e-cigarettes and related products under the 2026 Finance Bill. Budget Minister Delegate Fouzi Lekjaa argued that raising excise duties would not reduce demand and would instead encourage smuggling. Opposition groups emphasized the growing health risks and rising popularity of vaping among young people.

Nov.13 by 2FIRSTS.ai

Smoore and EVE Energy Sign Procurement Framework Agreement Covering 2026–2028 Cell Supply

Smoore and EVE Energy have signed a procurement framework agreement for 2026–2028, under which Smoore Group will continue purchasing battery cells and related products. The agreement sets no specific transaction amount; actual figures will be determined by future orders, reflecting both parties’ intention to secure and extend their supply chain cooperation over the next three years.

Nov.21

Philippines’ DTI Proposes Mandatory Advertising Permits for Vape Products

The Philippine Department of Trade and Industry (DTI) has released a draft Department Administrative Order (DAO) seeking public feedback on a new permitting system for advertising and promoting vaporized nicotine and non-nicotine products.

Dec.08 by 2FIRSTS.ai

Germany OLG Cologne: Touchscreen Vape Use Violates Driving “Phone Ban”

Germany’s OLG Cologne ruled that adjusting an e-cigarette touchscreen while driving violates the “phone ban” under road traffic law. The driver, caught changing vape settings on the highway, was fined €150 and received one penalty point, as the court said such actions pose significant distraction risks.